表紙
市場調査レポート

広場恐怖症:世界の治験レビュー

Agoraphobia Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 304749
出版日 ページ情報 英文 65 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
広場恐怖症:世界の治験レビュー Agoraphobia Global Clinical Trials Review, H1, 2014
出版日: 2014年05月26日 ページ情報: 英文 65 Pages
概要

当レポートでは、広場恐怖症に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 広場恐怖症
  • 当レポートの概要

各地域における治験状況

各国の治験件数と平均被験者数

  • アジア太平洋の主要国における治験件数
  • 欧州の主要国における治験件数
  • 北米の主要国における治験件数
  • 中南米の主要国における治験件数

G7諸国における治験件数:中枢神経系疾患の治験件数に対する広場恐怖症の比率

G7諸国における治験件数:フェーズ(相)別

G7諸国における治験件数:進捗状況別

E7(新興7カ国)における治験件数:中枢神経系疾患の治験件数に対する広場恐怖症の比率

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Bluefish Pharmaceuticals AB
    • Pfizer Inc.
    • Forest Laboratories, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Charite - Universitatsmedizin Berlin
    • Federal University of Rio de Janeiro
    • Sorlandet Hospital HF
    • Ministry of Education and Research, Germany
    • St. Elisabeth Hospital
    • National Institute of Mental Health
    • New York State Psychiatric Institute
    • VU University Medical Center
    • Hamilton Health Sciences
    • Hospices Civils de Lyon

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2170CTIDB

GlobalData's clinical trial report, "Agoraphobia Global Clinical Trials Review, H1, 2014" provides data on the Agoraphobia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Agoraphobia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Agoraphobia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Agoraphobia
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Agoraphobia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Agoraphobia to Central Nervous System Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Agoraphobia Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Bluefish Pharmaceuticals AB
      • Clinical Trial Overview of Bluefish Pharmaceuticals AB
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Forest Laboratories, Inc.
      • Clinical Trial Overview of Forest Laboratories, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • Federal University of Rio de Janeiro
      • Clinical Trial Overview of Federal University of Rio de Janeiro
      • Sorlandet Hospital HF
      • Clinical Trial Overview of Sorlandet Hospital HF
      • Ministry of Education and Research, Germany
      • Clinical Trial Overview of Ministry of Education and Research, Germany
      • St. Elisabeth Hospital
      • Clinical Trial Overview of St. Elisabeth Hospital
      • National Institute of Mental Health
      • Clinical Trial Overview of National Institute of Mental Health
      • New York State Psychiatric Institute
      • Clinical Trial Overview of New York State Psychiatric Institute
      • VU University Medical Center
      • Clinical Trial Overview of VU University Medical Center
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
      • Hospices Civils de Lyon
      • Clinical Trial Overview of Hospices Civils de Lyon
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Agoraphobia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Agoraphobia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Agoraphobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Agoraphobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Agoraphobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Agoraphobia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Agoraphobia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bluefish Pharmaceuticals AB, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Rio de Janeiro, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sorlandet Hospital HF, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Education and Research, Germany, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Elisabeth Hospital, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014*
  • Agoraphobia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2014*

List of Figures

  • Agoraphobia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Agoraphobia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Agoraphobia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Agoraphobia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Agoraphobia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Agoraphobia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Agoraphobia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Agoraphobia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Agoraphobia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top